tirzepatide fertility GLP-1 Weight-Loss Medications & GLP-1s and Fertility - Endocrinology

You will receive any updated Ebooks available through our program

[81] Trials for cardiovascular health [edit] In March 2024, the US Food and Drug Administration expanded the indication for semaglutide (brand name Wegovy) to reduce the risk of cardiovascular death, heart attack, and stroke in adults with cardiovascular disease and who are either obese or overweight

However, the timeline varies somewhat based on individual factors like kidney function, metabolism, and how long youve been taking the medication

HoJDChauBRodgersLLuFWilburKLOttoKAet al

Am J Physiol (1999) 277:G82937

Who Can Benefit from Compounded Semaglutide